insights_auto
Outlook: 67.5% bullish·5.0% bearish
Go to analysischevron_right
AZN:LON
AstraZeneca PLC (US)
GBX १२,५०६.००
arrow_downward
-१.५१%(-१९२.००) 1D
अक्टोबर १६, १७:१५:०० GMT+१ · GBX
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AZN...
Open
GBX १२,५०६.००
High
GBX १२,५७६.००
Low
GBX १२,४१८.००
Mkt. cap
२.६० खरब
Avg. vol.
२८.८३ लाख
Volume
२८.७७ लाख
Dividend
१.९१%
Quarterly dividend
GBX ५९.७५
Ex-dividend date
२०२६ अगस्ट ६
P/E ratio
२४.७८
52-wk high
GBX १५,७३२.००
52-wk low
GBX ९,८९२.००
EPS
GBX ५.०५
Shares outstanding
१.५५ अरब
No. of employees
९६ हजार
Open
GBX १२,५०६.००
High
GBX १२,५७६.००
Low
GBX १२,४१८.००
Mkt. cap
२.६० खरब
Avg. vol.
२८.८३ लाख
Volume
२८.७७ लाख
Dividend
१.९१%
Quarterly dividend
GBX ५९.७५
Ex-dividend date
२०२६ अगस्ट ६
P/E ratio
२४.७८
52-wk high
GBX १५,७३२.००
52-wk low
GBX ९,८९२.००
EPS
GBX ५.०५
Shares outstanding
१.५५ अरब
No. of employees
९६ हजार
News stories
From web sources and news partners
ad-hoc-news.de
·
४ घण्टा पहिले
AstraZeneca stock: RBC keeps GBp 14,500 target for AstraZeneca stock
Yahoo Finance
·
४ घण्टा पहिले
AstraZeneca’s Shares Have Fallen, but Is 14.6x Forward Earnings a Buying Opportunity?
The Statesman
·
५ घण्टा पहिले
Fadnavis praises AstraZeneca for opening Mumbai office, thanks pharma company for COVID-19 vaccine
Traders Union
·
१२ घण्टा पहिले
AstraZeneca shares technical analysis: Upward price move confirms strong near-term momentum
Profile
AstraZeneca plc is a Swedish–British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.
The company was founded in 1999 through the merger of the Swedish Astra AB and the British Zeneca Group. Zeneca shareholders received 53.5% of the shares, while Astra shareholders received the remaining 46.5%. Its portfolio includes primary and speciality care, coverage for rare diseases, and a robust global presence across various regions. Since the merger it has been among the world's largest pharmaceutical companies and has made numerous corporate acquisitions, including Cambridge Antibody Technology, MedImmune, Spirogen and Definiens. It has its research and development concentrated in three strategic centres: Cambridge, England; Gothenburg, Sweden; and Gaithersburg, Maryland, US.
AstraZeneca traces its earliest corporate history to 1913, when Astra AB was formed by a large group of doctors and apothecaries in Södertälje. Wikipedia
About AstraZeneca PLC (US)
CEOPascal Soriot
Employees९६.१ हजार
Founded१९९९ अप्रिल ६
Headquartersक्याम्ब्रिज, Cambridgeshire, संयुक्त अधिराज्य
Sector-
Websiteastrazeneca.com